Articles by Rachel Lutz - Page 3

Latest Articles

Early Clot-Removal Surgery Means Less Post-Stroke Disability
  |  Rachel Lutz
Following a stroke, the sooner a patient undergoes clot-busting endovascular thrombectomy, the better their outcomes are, in terms of severity of disability.
Minimizing C. difficile Risk in Long Term Care Facilities
  |  Rachel Lutz
C. diff guideline highlights the need for international agreement.
Fidaxomicin Effective for Patients Experiencing First C. difficile Infection Episode
  |  Rachel Lutz
Patients using fidaxomicin for C diff infection experienced no recurrences..
Non-Frozen Oral Capsules Could be Next Step in C. difficile Treatment
  |  Rachel Lutz
Researchers, for the first time, used the lyophilized non-frozen oral capsule RBX7455 to treat a patient with recurrent Clostridium difficile (C. difficile) infection.
Central Sleep Apnea a Problem for Multiple Sclerosis Patients
  |  Rachel Lutz
People with multiple sclerosis tend to have sleep apnea, but not the usual kind, a study found.
Updating Diagnostics, Attitudes, and Treatments Surrounding Borderline Personality Disorder
  |  Rachel Lutz
There is an urgent need to improve diagnostic abilities and management of borderline personality disorder, despite significant breakthroughs.
Multiple Sclerosis Associated with Disruption of Microbiome
  |  Rachel Lutz
Looking at post-mortem brain samples, researchers found that multiple sclerosis is associated with an abundance of bacteria and molecular diversity.
FMT Is Not a Cure-All
  |  Rachel Lutz
While effective for Clostridium difficile (C. difficile) infection in irritable bowel syndrome (IBS) patients, fecal microbiota transplants did not relieve the IBS itself.
Multiple Sclerosis: Neural Stem Cells Hold Key to New Therapies?
  |  Rachel Lutz
Finding neural stem cells in the brain’s meninges could lead to new therapies for multiple sclerosis patients.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$